Skip to main content
logo
Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · Real-Time Price · USD
1.140
-0.040 (-3.39%)
May 15, 2026, 2:12 PM EDT - Market open

Sonoma Pharmaceuticals Income Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Revenue
17.7214.2912.7413.2712.6318.63
Revenue Growth (YoY)
26.83%12.20%-4.05%5.10%-32.21%3.91%
Cost of Revenue
10.968.827.998.88.6412.07
Gross Profit
6.765.474.754.483.996.56
Selling, General & Admin
7.397.367.588.849.769.45
Research & Development
2.141.811.870.210.130.56
Total Operating Expenses
9.539.189.459.059.8810.01
Operating Income
-2.77-3.71-4.7-4.57-5.89-3.45
Other Non-Operating Income (Expense)
-0.680.8-0.33-0.610.47-0.45
Total Non-Operating Income (Expense)
-0.680.8-0.33-0.610.47-0.45
Pretax Income
-3.45-2.91-5.03-5.18-5.42-3.9
Provision for Income Taxes
0.08-0.550.20.030.33-0.71
Net Income
-3.37-3.46-4.84-5.15-5.09-3.95
Earnings From Discontinued Operations
-----0.67
Net Income to Common
-3.37-3.46-4.84-5.15-5.09-3.95
Shares Outstanding (Basic)
210000
Shares Outstanding (Diluted)
210000
Shares Change (YoY)
60.67%172.75%168.12%27.93%32.92%35.14%
EPS (Basic)
-1.95-2.79-10.63-30.40-38.40-39.40
EPS (Diluted)
-1.95-2.79-10.63-30.40-38.40-39.40
Shares Outstanding
1.731.630.780.250.160.1
Free Cash Flow
-3.72-0.17-2.4-6.42-4.39-3.56
Free Cash Flow Per Share
-2.25-0.14-5.27-37.84-33.06-35.64
Gross Margin
38.16%38.25%37.26%33.73%31.62%35.21%
Operating Margin
-15.61%-25.97%-36.91%-34.43%-46.62%-18.51%
Profit Margin
-19.92%-16.50%-41.04%-39.31%-45.53%-24.77%
FCF Margin
-20.99%-1.18%-18.85%-48.38%-34.72%-19.09%
EBITDA
-2.63-3.57-4.53-4.45-5.7-3.22
EBITDA Margin
-14.83%-25.00%-35.53%-33.49%-45.15%-17.30%
EBIT
-2.77-3.71-4.7-4.57-5.89-3.45
EBIT Margin
-15.61%-25.97%-36.91%-34.43%-46.62%-18.51%
Effective Tax Rate
-2.32%18.92%-3.90%-0.64%-6.13%18.27%
Updated Feb 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q